Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis
Open Access
- 1 February 1993
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 36 (2) , 181-189
- https://doi.org/10.1002/art.1780360207
Abstract
Objective. To determine the concentrations of human stromelysin-1, collagenase, tissue inhibitor of metalloproteinases (TIMP), and proteoglycan fragments in knee synovial fluid in patients with injury to the meniscus or anterior cruciate ligament, posttraumatic osteoarthritis, primary osteoarthritis, or pyrophosphate arthritis. Methods. Synovial fluid samples were collected from patients with knee disease diagnosed arthroscopically and radiologically. Concentrations of stromelysin-1, collagenase, and TIMP-1 were determined by sandwich immunoassay, using monoclonal and polyclonal antibodies. Fragments of cartilage proteoglycan containing the chondroitin sulfate-binding region were determined by immunoassay with a polyclonal antibody. Results. Average concentrations of metalloproteinases, TIMP, and proteoglycan fragments in joint fluid were significantly elevated in patients from all disease groups as compared with volunteers with healthy knees (reference group). Stromelysin concentrations in disease groups averaged 15–45 times that of the reference group. The molar ratios between stromelysin and collagenase varied between 10 and 150. The molar ratio between total stromelysin and free TIMP was 0.5 in the reference group and between 1.6 and 5.3 in the disease groups. Conclusion. Stromelysin concentration in joint fluid is a parameter that distinguishes diseased joints from healthy joints, with a sensitivity of 84% and a specificity of 90%. The high concentrations of metalloproteinase relative to TIMP in joint fluid from patients with the conditions studied may be associated with cartilage matrix degradation in these arthritides.Keywords
This publication has 43 references indexed in Scilit:
- Synovial fluid analysis of two groups of proteoglycan epitopes distinguishes early and late cartilage lesionsArthritis & Rheumatism, 1992
- Detection of Stromelysin and Collagenase in Synovial Fluid From Patients with Rheumatoid Arthritis and Posttraumatic Knee InjuryArthritis & Rheumatism, 1992
- Markers of cartilage metabolism in arthrosisActa Orthopaedica, 1991
- Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritisArthritis & Rheumatism, 1990
- Increased levels of proteoglycan fragments in knee joint fluid after injuryArthritis & Rheumatism, 1989
- Evidence for metalloproteinase and metalloproteinase inhibitor imbalance in human osteoarthritic cartilage.Journal of Clinical Investigation, 1989
- Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid.Annals of the Rheumatic Diseases, 1986
- DIFFERENCE IN CARTILAGE PROTEOGLYCAN LEVEL IN SYNOVIAL FLUID IN EARLY RHEUMATOID ARTHRITIS AND REACTIVE ARTHRITISThe Lancet, 1985
- Structure of newly synthesised (35S)‐proteoglycans and (35s)‐proteoglycan turnover products of cartilage explant cultures from dogs with experimental osteoarthritisJournal of Orthopaedic Research, 1985
- Early changes in material properties of rabbit articular cartilage after meniscectomyJournal of Orthopaedic Research, 1983